Short Interest in CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Decreases By 87.6%

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) was the target of a large drop in short interest during the month of December. As of December 15th, there was short interest totalling 19,100 shares, a drop of 87.6% from the November 30th total of 154,200 shares. Based on an average trading volume of 232,200 shares, the days-to-cover ratio is presently 0.1 days.

CNBX Pharmaceuticals Stock Up 7.8 %

OTCMKTS:CNBX traded up $0.00 during midday trading on Thursday, hitting $0.01. The stock had a trading volume of 456,588 shares, compared to its average volume of 181,636. The stock has a 50-day moving average of $0.01 and a 200 day moving average of $0.01. CNBX Pharmaceuticals has a one year low of $0.01 and a one year high of $0.02.

CNBX Pharmaceuticals Company Profile

CNBX Pharmaceuticals Inc, a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome.